10-Q: Investview Inc. Reports Mixed Results in Q3 2024 Amidst Revenue Declines and Strategic Acquisitions

Sentiment:

Quarterly Report


Investview Inc. experienced a decrease in revenue during the third quarter of 2024, while also making strategic acquisitions and managing ongoing legal challenges.

Worse than expectedThe company's revenue decreased significantly in Q3 2024 compared to Q3 2023, indicating worse than expected performance.The company's net income decreased for the nine months ended September 30, 2024, compared to the same period in 2023, indicating worse than expected performance.

Summary

  • Investview Inc. reported a net revenue of $11.7 million for the three months ended September 30, 2024, a decrease of 39% compared to $19.2 million in the same period of 2023.
  • The company's subscription revenue decreased by 31% to $11.2 million, while mining revenue fell by 80% to $0.6 million, and cryptocurrency revenue was $0 due to the discontinuation of related packages.
  • Operating costs decreased by 26% to $12.4 million, primarily due to lower commissions and cost of sales, but were offset by a $977 thousand impairment expense on data processing equipment.
  • For the nine months ended September 30, 2024, net revenue was $40.5 million, a 19% decrease from $50 million in the same period of 2023.
  • The company reported a net income of $1.4 million for the nine months ended September 30, 2024, compared to $3 million in the same period of 2023.
  • Investview's cash and cash equivalents stood at $24.5 million as of September 30, 2024, with a working capital of $17.4 million.
  • The company made strategic acquisitions, including Renu Laboratories, Goldmans Pharmaceuticals LLC, and a stake in ELRT Technologies LLC, and repurchased shares from former related parties.
  • Investview is also involved in ongoing litigation with a credit card processor over $1.87 million in withheld funds.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with significant revenue declines and ongoing legal issues, but also strategic acquisitions and a strong cash position. The overall sentiment is cautiously negative due to the revenue downturn and litigation risks.

Positives

  • Operating costs decreased by 26% in Q3 2024, indicating improved cost management.
  • The company has a strong cash position with $24.5 million in cash and cash equivalents as of September 30, 2024.
  • Investview made strategic acquisitions in the health and wellness sector, expanding its business portfolio.
  • The company has a positive working capital of $17.4 million as of September 30, 2024.
  • The company recognized a gain on cryptocurrency transactions of $284 thousand for the nine months ended September 30, 2024.

Negatives

  • Total revenue decreased by 39% in Q3 2024, indicating a significant downturn in business performance.
  • Subscription revenue decreased by 31% in Q3 2024, reflecting challenges in the direct sales industry.
  • Mining revenue decreased by 80% in Q3 2024, impacted by external factors such as the Bitcoin Halving and power curtailments.
  • The company recorded a $977 thousand impairment expense on data processing equipment in Q3 2024.
  • Investview is involved in ongoing litigation to recover $1.87 million from a credit card processor, creating uncertainty.
  • The company's cryptocurrency revenue was $0 for the nine months ended September 30, 2024, due to the discontinuation of related packages.

Risks

  • The company faces risks related to the direct selling business model, including potential regulatory scrutiny and allegations of fraudulent schemes.
  • The ongoing litigation with a credit card processor could result in a significant bad debt expense if the funds are not recovered.
  • The company's mining operations are subject to external factors such as Bitcoin Halving, network difficulty, and power curtailments.
  • The company's financial performance is sensitive to fluctuations in cryptocurrency prices.
  • The company's ability to meet its debt service obligations and achieve its objectives depends on its cash flow from operations and access to capital markets.

Future Outlook

The company plans to develop a business unit that will offer investors an online trading platform and expand its sales and marketing initiatives by developing and offering proprietary products through its global distribution network and direct to consumers platform.

Management Comments

  • Management believes they will have sufficient resources to meet debt service obligations and be able to meet their objectives.
  • Management does not believe there are any liquidity issues as of September 30, 2024.

Industry Context

The company's performance is affected by broader industry trends, including the slowdown in the direct sales industry, the volatility of cryptocurrency markets, and the regulatory environment for direct selling programs. The company is also expanding into the health and wellness sector, which is a growing market.

Comparison to Industry Standards

  • The decrease in subscription revenue reflects a broader trend of challenges in the direct sales industry, as seen in companies like Herbalife and Nu Skin, which have also reported declining sales in recent periods.
  • The significant drop in mining revenue is consistent with the impact of the Bitcoin Halving event, which has affected other mining companies such as Marathon Digital and Riot Platforms, which have also reported reduced mining output.
  • The company's strategic acquisitions in the health and wellness sector are similar to moves by other companies seeking to diversify their revenue streams, such as those seen in the consumer goods and nutraceutical industries.
  • The ongoing litigation with a credit card processor is a unique challenge for Investview, but it highlights the risks associated with payment processing in the direct sales and cryptocurrency industries, which have seen similar issues with other companies.

Legal Proceedings

  • The company is involved in litigation with a credit card processor to recover approximately $1.87 million in withheld funds.
  • The company received a subpoena from the SEC in November 2021 and continues to cooperate with the investigation.
  • The company is involved in a dispute with Joseph Cammarata, a former officer, regarding a promissory note and the potential conversion of the note into common shares.

Related Party Transactions

  • The company repurchased shares from former related parties, including Mario Romano, Annette Raynor, Ryan Smith, and Chad Miller.
  • The company has related-party debt with DBR Capital, LLC, an entity controlled by a member of the Board of Directors.
  • The company has a working capital promissory note with SSA Technologies LLC, an entity controlled by a former CEO.

Stakeholder Impact

  • Shareholders may be concerned about the decrease in revenue and net income.
  • Employees may be affected by the company's restructuring and strategic changes.
  • Customers may be impacted by changes in product offerings and services.
  • Suppliers may be affected by the company's acquisitions and changes in business operations.
  • Creditors may be concerned about the company's ability to meet its debt obligations.

Next Steps

  • The company will continue to pursue litigation to recover funds from the credit card processor.
  • The company will integrate the acquired businesses and assets of Renu Labs.
  • The company will continue to develop its online trading platform.
  • The company will continue to monitor and respond to any inquiries from the SEC.

Key Dates

DateDescription
2017-04-01Investview closed on a Contribution Agreement with Wealth Generators, LLC.
2017-06-06Investview entered into an Acquisition Agreement with Market Trend Strategies, LLC.
2020-04-27Investview received proceeds from DBR Capital, LLC and entered into a convertible promissory note.
2020-05-27Investview received proceeds from DBR Capital, LLC and entered into a convertible promissory note.
2020-11-09Investview received proceeds from DBR Capital, LLC and entered into a convertible promissory note.
2021-03-22Investview entered into Securities Purchase Agreements to purchase the operating assets of SSA Technologies LLC.
2021-08-17Investview completed a public offering of 252,192 units at $25 per unit.
2023-09-29Investview closed on the purchase of shares of common stock under the terms of a Stock Purchase and Release Agreement with Mario Romano and Annette Raynor.
2024-02-07Investview closed on the purchase of shares of common stock under the terms of a Stock Purchase and Release Agreement with Ryan Smith and Chad Miller.
2024-09-30End of the reporting period for the quarterly report.
2024-10-11Investview closed on the purchase of the business and assets of Renu Laboratories, Inc., along with a 100% ownership interest in Goldmans Pharmaceuticals LLC and a 50% ownership interest in ELRT Technologies, LLC.
2024-10-25Investview entered into an agreement with three non-affiliate shareholders to repurchase 121 million shares of common stock.
2024-11-01Investview entered a lease agreement for 12,500 rentable square feet for Renu Labs.
2024-11-12Date of the share count for the report.

Keywords

Investview, financial technology, subscription revenue, mining revenue, cryptocurrency, Bitcoin, direct selling, litigation, acquisitions, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.